Sign up to save your podcasts
Or
Share Advances in Immunotherapy for Lung Cancer: Leaps and Limits
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Advances in Immunotherapy for Lung Cancer: Leaps and Limits
Rachel Sanborn, MD, Medical Director of Clinical Research, Robert W. Franz Cancer Center and Earle A. Chiles Research Institute - A Division of Providence Cancer Institute, Portland Oregon
CME Credit Available for all Providence Providers
In order to claim CME credit, please click on the following link: https://forms.office.com/r/YsSFEpMb5g or copy & paste into your browser).
Accreditation Statement: Providence Oregon Region designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 creditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Providence Oregon Region is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Planning Committee & Faculty Disclosure: The planning committee have indicated no relevant financial relationships with an ACCME-defined ineligible company.Faculty:Since Dr. Sanborn is very involved in the research end of Medicine, she has a consulting role with various Pharmaceutic Companies and has presented research at their conferences and scientific meetings. Any conflicts of interest will be addressed and mitigated for compliance to the commercialsupport and content validity guidelines of Providence Oregon Region CME prior to this live event.
All financial relationships (if any) have been mitigated.
Original Date: June 18, 2026
End Date: June 17, 2027
View all episodes
By Providence Oregon Region
5
33 ratings
Rachel Sanborn, MD, Medical Director of Clinical Research, Robert W. Franz Cancer Center and Earle A. Chiles Research Institute - A Division of Providence Cancer Institute, Portland Oregon
CME Credit Available for all Providence Providers
In order to claim CME credit, please click on the following link: https://forms.office.com/r/YsSFEpMb5g or copy & paste into your browser).
Accreditation Statement: Providence Oregon Region designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 creditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Providence Oregon Region is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Planning Committee & Faculty Disclosure: The planning committee have indicated no relevant financial relationships with an ACCME-defined ineligible company.Faculty:Since Dr. Sanborn is very involved in the research end of Medicine, she has a consulting role with various Pharmaceutic Companies and has presented research at their conferences and scientific meetings. Any conflicts of interest will be addressed and mitigated for compliance to the commercialsupport and content validity guidelines of Providence Oregon Region CME prior to this live event.
All financial relationships (if any) have been mitigated.
Original Date: June 18, 2026
End Date: June 17, 2027